SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair - GZTR -- Ignore unavailable to you. Want to Upgrade?


To: KLH who wrote (208)7/6/1999 8:09:00 PM
From: Machaon  Respond to of 405
 
Looks like Mother Market is throwing up all over Gynzyme Corporation's tracking stocks. It parallels Sammy Sosa with a bat in his hand, waiting for someone to pitch him a Genzyme tracking stock so he can cream it!

But, that's the good news. GZTR is not alone. GZMO and GZSP are also getting slaughtered. So, I assume that the merciless bloodletting of GZTR is not news related.

CEO of Genzyme recently bought around 290,000 shares of GZTR. President of GZTR is predicting around a 66% Carticel annual growth rate going forward, even after the 1st quarter stunk up the place. His forecasts have really missed the mark in the past, but every dog has it's day once in a while.

GZTR is also supposed to clinically test their tacking tools in Europe in the 3rd quarter. If they work, it should cause a major improvement in the Carticel procedure.

Smells like a buying opportunity to me.



To: KLH who wrote (208)7/9/1999 9:33:00 AM
From: Exacctnt  Read Replies (2) | Respond to of 405
 
KLH, The Great Experiment Part II. Call me a glutton for punishment, I have just about completed another purchase for an additional 10,000 shares. The first 10 could have been sold for a 20-25% gain at one point since the original purchase, but I wanted more.<g> I still maintain that the downside risk is minimal and the upside is worth placing an additional investment ( or maybe I should say, bet).

I am viewing the investment/bet as a trading vehicle depending upon the movement in price of the stock.

Yesterday's bid and ask pricing was somewhat encouraging, however, there is no doubt that there is a major seller out there that kept the ask price stable all day at 1 15/16. Eventually, that seller will complete their sale and hopefully the stock price will get out of this rut.

A year from now we may be able to look back at these prices and marvel at the incredible buying opportunity. Time will tell.

Regards